Klivira
Request demo

Streamlining Auvelity Prior Authorization for Dermatology Practices

Managing Auvelity prior authorization for dermatology patients adds to the significant administrative burden faced by skin care practices. Klivira automates this process, ensuring faster approvals and reduced workload.

Dermatology practices navigate a complex landscape of prior authorizations for biologics, specialty drugs, and procedures. While Auvelity is a high-volume PA target, its management within a dermatology setting exemplifies the broader need for efficient, automated solutions. Klivira empowers revenue cycle directors and PA coordinators to streamline these critical workflows, improving patient access and operational efficiency.

Addressing Auvelity Prior Authorization in Dermatology Settings

Auvelity is identified as a high-volume prior authorization (PA) target across various commercial, Medicare Advantage, and Medicaid managed care plans. For dermatology practices, managing PA for such specialty medications, whether for primary dermatological conditions or patient comorbidities, adds to an already complex administrative workflow. Efficient processing of drugs like Auvelity is crucial to maintain patient access and operational efficiency.

The Broader Prior Authorization Landscape in Dermatology

Dermatology practices routinely navigate PA requirements for a wide spectrum of treatments. This includes biologics for chronic conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa, alongside specialty topicals and complex procedures such as Mohs micrographic surgery. The administrative burden extends to ensuring timely approvals for all specialty drugs, including those like Auvelity, that may be part of a patient's overall treatment plan.

Key Dermatology PA Categories

  • Biologics for psoriasis and psoriatic arthritis (e.g., TNF, IL-17, IL-23 inhibitors)
  • Biologics for atopic dermatitis (e.g., dupilumab, tralokinumab, JAK inhibitors)
  • Hidradenitis suppurativa biologics (e.g., adalimumab, secukinumab)
  • Mohs micrographic surgery for non-melanoma skin cancers
  • Advanced skin cancer treatments (e.g., immunotherapy, targeted therapy)
  • Phototherapy (e.g., narrowband UVB, PUVA, excimer laser)

Documentation Considerations for Specialty Drugs in Dermatology

While specific documentation for Auvelity is payer and indication-dependent, the general principles for specialty drug PA in dermatology emphasize comprehensive patient history, evidence of failed prior therapies, and adherence to clinical guidelines. For dermatological biologics, this often involves precise disease severity scores and pre-biologic screening results.

Common Documentation Requirements in Dermatology PA

  • Diagnosis and severity scores (e.g., PASI/BSA for psoriasis, EASI/SCORAD for atopic dermatitis)
  • Documentation of prior topical or systemic therapy trials
  • Pre-biologic screening results (e.g., TB, hepatitis) where applicable
  • Age-appropriate criteria for specific biologics
  • Conformance with appropriate use criteria (AUC) for procedures like Mohs surgery

Klivira's Role in Streamlining Prior Authorization for Dermatology

Klivira automates the prior authorization workflow for high-volume specialty drugs, including those like Auvelity, and complex dermatological treatments. By integrating directly with EMRs and payer portals, Klivira reduces manual intervention, accelerates approval times, and helps dermatology practices manage their diverse PA needs more effectively.

Enhancing Dermatology Practice Efficiency with Klivira

Klivira's platform is designed to address unique dermatology PA challenges, such as periodic re-authorization for chronic biologic treatments and accurate medical-versus-pharmacy benefit routing. The system leverages AAD-guideline-aware logic for biologics and AUC validation for Mohs surgery, ensuring submissions align with payer requirements and minimizing common denial reasons.

Frequently asked questions

How does Klivira manage Auvelity prior authorizations across different payers?

Klivira connects directly with a broad network of commercial, Medicare Advantage, and Medicaid managed care plans. For high-volume PA targets like Auvelity, our platform streamlines submission and tracking, adapting to specific payer requirements to ensure efficient processing and reduce administrative overhead.

Can Klivira integrate with our dermatology EMR system to manage Auvelity and other PAs?

Yes, Klivira offers robust integration capabilities with leading EMR systems used in dermatology. This allows for seamless data exchange, pre-population of PA forms, and automated submission directly from your existing clinical workflows, reducing manual data entry for all specialty drugs and procedures.

How does Klivira support the re-authorization process for chronic dermatology conditions?

Klivira includes features specifically designed for periodic re-authorization cycles common in chronic dermatology treatments. The platform tracks approval expiry dates, proactively initiates re-authorization workflows, and helps ensure continuous patient access to necessary biologics and other long-term therapies with minimal disruption.

Does Klivira assist with prior authorizations for dermatological procedures like Mohs surgery?

Absolutely. Klivira's platform incorporates appropriate use criteria (AUC) validation for procedures such as Mohs micrographic surgery. This helps ensure that submissions align with payer policies and clinical guidelines, reducing denials and accelerating approval for these critical dermatological procedures.

How does Klivira help dermatology practices comply with clinical guidelines for specialty drugs?

Klivira leverages AAD-guideline-aware step-therapy logic for biologics used in conditions like psoriasis and atopic dermatitis. While specific Auvelity guidelines are payer-dependent, our system helps ensure that all specialty drug submissions adhere to established clinical pathways and documentation best practices, minimizing common denial reasons.

Related coverage

Other auvelity prior authorization by payer

Other auvelity prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo